NCT06710951View on ClinicalTrials.gov

Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Dry Eye
Interventions
PROCEDURE

Change of normal concentration of povidone-iodine 5% to 1%

Normal concentration of povidone-iodine during anti-VEGF intravitreal injection was 5%. That concentration was utilized in the control group, and 1% in the experimental group.

Trial Locations (1)

04030

Asociación para Evitar la Ceguera en México I.A.P., Mexico City

All Listed Sponsors
lead

José Gerardo García Aguirre

OTHER

NCT06710951 - Effect of Povidone-iodine 5% Vs 1% on the Ocular Surface in Intravitreal Injections of Anti-VEGF | Biotech Hunter | Biotech Hunter